Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer - Basser, R L; Rasko, J EJ; Clarke, K; Cebon, J; Green, M D; Hussein, S; Menchaca, D; Tomita, D; Marty, J; Fox, R M; Begley, C G (Lancet, 1996)